HTA142 Potential Impact of Biomarker Guided-Decisions on Overtreatment in Immunotherapy for Non-Small Cell Lung Cancer Patients
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1600
https://www.valueinhealthjournal.com/article/S1098-3015(22)03805-0/fulltext
Section Title :
Section Order :
11153
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03805-0&doi=10.1016/j.jval.2022.09.1600